Group 1 - The Hang Seng Hong Kong Stock Connect Innovative Drug Index decreased by 1.1% at midday, while the CSI Hong Kong Stock Connect Pharmaceutical and Health Comprehensive Index fell by 0.8% [1] - The CSI Innovative Drug Industry Index rose by 0.6%, and the CSI Biotechnology Theme Index increased by 0.8%, with the CSI 300 Pharmaceutical and Health Index up by 0.5% [1] - The Hang Seng Hong Kong Stock Connect Innovative Drug Index has announced a revision to its compilation scheme, which officially took effect today [1] Group 2 - The revision explicitly excludes CXO companies, focusing solely on core innovative drug companies [1] - The revised Hang Seng Hong Kong Stock Connect Innovative Drug Index will be the first among ETF-tracked indices to achieve a "purity" level of 100% for innovative drug companies [1]
恒生创新药ETF（159316）半天获1000万份净申购，标的指数“提纯”落地，聚焦创新药投资机会
Sou Hu Cai Jing·2025-08-11 05:30